Zillow’s 482nd Market Rank Amid 44% Volume Drop and Insider Selloffs
On August 15, 2025, Zillow Group (Z) traded at $84.80, down 0.19% with a $0.20 billion trading volume—a 44.08% decline from the previous day’s activity. The stock ranked 482nd in trading volume across the market. Institutional ownership of Zillow remains significant, with 71.01% of shares held by institutional investors. Aigen Investment Management LP notably reduced its stake by 74.8% in the first quarter, retaining 4,976 shares valued at $341,000. Meanwhile, Vanguard Group Inc. and Ninety One UK Ltd increased their holdings during the same period.
Insider transactions also drew attention. Director April Underwood sold 595 shares at $86.01, reducing her ownership by 45.08%, while Director Thielke Claire Cormier sold 8,247 shares at $79.86, a 91.92% cut in her position. These sales added to a broader trend of insider divestment, with corporate insiders now owning 25.03% of the company. Analyst ratings remained mixed, with JPMorganJPM-- upgrading its price target to $94 and Wedbush reiterating an “outperform” rating, though nine analysts maintained a “hold” stance.
Zillow’s market fundamentals showed a 12-month low of $51.94 and a high of $89.39, with a market cap of $20.48 billion. The stock’s beta of 2.09 highlights its volatility relative to the S&P 500. Despite recent analyst optimism, the stock’s performance has been constrained by broader market dynamics and sector-specific challenges.
The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to present yielded a total profit of $10,720, with cumulative returns of 1.08 times the initial investment. This underscores the role of liquidity in short-term trading strategies, though outcomes remain subject to market volatility.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet